Michael R. Myers

Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A

Glenda E. Bilder, Tara Wentz, Robert J. Leadley et al. · Circulation · 1999 · 88 citations

Medicine, Cardiology, Pharmacology +15

Low temperatures favor kinetic 1,4- over 1,2-addition of organolithiums to .alpha.-enones. The crucial role of ion-pairing

Theodore Cohen, William D. Abraham, Michael R. Myers · Journal of the American Chemical Society · 1987 · 54 citations

Natural Sciences, Chemistry, Analytical Chemistry +6

The preparation and sar of 4-(anilino), 4-(phenoxy), and 4-(thiophenoxy)-quinazolines: Inhibitors of p56lck and EGF-R tyrosine kinase activity

Michael R. Myers, Natalie N. Setzer, Alfred P. Spada et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 45 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituent

Michael R. Myers, Wei He, Barbara Hanney et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial

Aditya H. Gaur, Hilda Kizito, Wasana Prasitsueubsai et al. · The Lancet HIV · 2016 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +17